Skip to main content
Year archive

VIVOZON PHARMACEUTICAL CO., LTD. — 2023 filings

All 53 regulatory filings released by VIVOZON PHARMACEUTICAL CO., LTD. (082800) in 2023, sourced directly from the official regulator.

53 Filings
2023 Period
2023 filings (53)
Filing Released Lang
전환가액의조정(제20회차)
Share Issue/Capital Change
2023-12-20 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제20회차)
Capital/Financing Update
2023-12-20 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2023-12-14 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2023-12-01 Korean
투자판단관련주요경영사항(어나프라주(오피란제린염산염) 품목허가 신청)
Regulatory Filings
2023-11-22 Korean
전환가액의조정(제20회차)
Capital/Financing Update
2023-11-20 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
주권매매거래정지해제(액면병합 주권 변경상장)
Delisting Announcement
2023-11-09 Korean
전환가액의조정(제15, 19, 20회차)
Share Issue/Capital Change
2023-10-24 Korean
전환가액의조정(제20회차)
Capital/Financing Update
2023-10-20 Korean
주권매매거래정지(주식의 병합, 분할 등 전자등록 변경, 말소)
Delisting Announcement
2023-10-17 Korean
[기재정정]주식병합결정
Share Issue/Capital Change
2023-10-06 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-10-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2023-09-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-09-25 Korean
자기주식취득결과보고서
Transaction in Own Shares
2023-09-21 Korean
주주총회소집공고
AGM Information
2023-09-20 Korean
전환가액의조정(제20회차 CB)
Capital/Financing Update
2023-09-20 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares
2023-09-19 Korean
주식병합결정
Share Issue/Capital Change
2023-08-24 Korean
주주총회소집결의
AGM Information
2023-08-24 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-08-24 Korean
전환가액의조정(제20회차)
Capital/Financing Update
2023-08-21 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
[기재정정]사업보고서 (2022.12)
Annual Report FY 2022
2023-07-28 Korean
전환가액의조정(제20회차)
Capital/Financing Update
2023-07-20 Korean
대표이사변경
Board/Management Information
2023-06-30 Korean
주권매매거래정지(중요한 영업정지)
Delisting Announcement
2023-06-30 Korean
주요사항보고서(영업정지)
Regulatory Filings
2023-06-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2023-06-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-06-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-06-09 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-04-25 Korean
불성실공시법인지정(공시번복)
Regulatory Filings
2023-04-18 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-30 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-28 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-28 Korean
불성실공시법인지정예고(공시번복)
Regulatory Filings
2023-03-24 Korean
기타경영사항(자율공시)(감사보고서 제출 지연)
Regulatory Filings
2023-03-22 Korean
주주총회집중일개최사유신고
AGM Information
2023-03-15 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2023-03-15 Korean
주주총회소집공고
AGM Information
2023-03-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-03-10 Korean
[기재정정]투자판단관련주요경영사항(오피란제린 주사제 한국 임상3상 Topline 결과 발표)
Legal Proceedings Report
2023-03-06 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change
2023-02-28 Korean
[기재정정]전환청구권행사(제19회차)
Share Issue/Capital Change
2023-02-28 Korean
[기재정정]수시공시의무관련사항(공정공시)(코로나19 검체수송배지 등 공급계약(기본계약) 해지 결정)
Regulatory Filings
2023-02-24 Korean
전환청구권행사(제19회차)
Share Issue/Capital Change
2023-02-22 Korean
투자판단관련주요경영사항((오피란제린 주사제 한국 임상3상 유효성 일차평가항목 결과 발표))
Regulatory Filings
2023-02-07 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change
2023-01-18 Korean
주요사항보고서(유상증자결정)
Capital/Financing Update
2023-01-09 Korean